TIM-3 therapy for Alzheimer’s is emerging as a promising avenue in the quest for effective Alzheimer’s treatment, leveraging insights from cancer therapy.Recent research reveals that by inhibiting the TIM-3 checkpoint molecule, microglia— the brain's immune cells—can effectively combat amyloid plaques that contribute to cognitive decline.